Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Business Cycle Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseHDFCHDFC
NAV₹16.4070₹23.6750
NAV date20 Nov 202620 Nov 2026
History4.0 years3.1 years
Expense ratio1.1%1.1%
Stars★★★★★★★★★★
Growth Score50.5094.50

Returns

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+7.69%+12.97%
3 months+1.91%+7.13%
6 months+11.83%+17.84%
YTD+7.72%+33.73%
1 year+5.98%+32.20%
3 years (CAGR)+12.01%+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+13.24%+31.83%

Risk

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility15.5%15.8%
Downside volatility10.3%8.5%
Sharpe0.361.53
Sortino0.532.86
Calmar0.672.06
Return / risk0.781.95
Deepest fall−18.04%−14.91%
Days to recover133126
Below its high+0.00%+0.00%

Against benchmark

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha+0.41%+7.54%
Beta0.920.97
R²90.6%85.0%
Up capture95.3%108.9%
Down capture92.0%71.0%
Tracking error4.9%6.1%
Information ratio−0.011.17
Treynor0.050.24

Consistency

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+39.99%+67.01%
Middle 1-year+6.68%+23.25%
Worst 1-year−6.17%+1.71%
1-year periods with a loss9.1%0.0%
Middle 3-year+12.75%+30.22%
Positive months61.1%72.2%
Best day+4.12%+3.18%
Worst day−6.25%−3.61%
Worst 5% day−1.52%−1.51%
Positive days54.9%58.3%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+8.57%+27.71%
1-year XIRR+15.07%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth